In the BP trial , risk of the primary outcome was lower in the groups intensively treated for glycemia ( hazard ratio -LSB- HR -RSB- @ ; @ % CI @-@ @ ) , BP ( HR @ ; @ % CI @-@ @ ) , or both ( HR @ ; @ % CI @-@ @ ) compared with combined standard BP and glycemia treatment .